Wing Kei Yip
Finanzdirektor/CFO bei Rnaimmune, Inc.
Aktive Positionen von Wing Kei Yip
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Rnaimmune, Inc.
 Rnaimmune, Inc. BiotechnologyHealth Technology Rnaimmune, Inc. develops a technology for the development of cancer therapies. It focuses on the areas such as infectious diseases, immuno oncology, and rare diseases. The company is headquartered in Gaithersburg, MD. | Finanzdirektor/CFO | - | - |
Karriereverlauf von Wing Kei Yip
Ehemalige bekannte Positionen von Wing Kei Yip
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SIRNAOMICS LTD. | Finanzdirektor/CFO | 15.11.2022 | 31.05.2024 |
| Corporate Officer/Principal | 01.12.2020 | 15.11.2022 | |
Rothschild (Hong Kong) Ltd.
 Rothschild (Hong Kong) Ltd. Investment ManagersFinance Part of Rothschild Concordia SAS, Rothschild (Hong Kong) Ltd. is a Chinese company that provides financial advisory services. The company is based in Hong Kong, Hong Kong. The CEO of the company is Yu Yu Yien. | Corporate Officer/Principal | 01.05.2010 | 01.08.2015 |
| KPMG Corporate Finance Ltd. | Corporate Officer/Principal | 01.08.2008 | 01.04.2010 |
Ausbildung von Wing Kei Yip
| University of Hong Kong | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Statistik
International
| Hong Kong | 4 |
| Vereinigte Staaten | 3 |
| Japan | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Finance | 3 |
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIRNAOMICS LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| KPMG Corporate Finance Ltd. | Finance |
Rothschild (Hong Kong) Ltd.
Rothschild (Hong Kong) Ltd. Investment ManagersFinance Part of Rothschild Concordia SAS, Rothschild (Hong Kong) Ltd. is a Chinese company that provides financial advisory services. The company is based in Hong Kong, Hong Kong. The CEO of the company is Yu Yu Yien. | Finance |
Rnaimmune, Inc.
Rnaimmune, Inc. BiotechnologyHealth Technology Rnaimmune, Inc. develops a technology for the development of cancer therapies. It focuses on the areas such as infectious diseases, immuno oncology, and rare diseases. The company is headquartered in Gaithersburg, MD. | Health Technology |
- Börse
- Insiders
- Wing Kei Yip
- Erfahrung